Electrophysiological actions of neuropeptide Y and its analogs: New measures for anxiolytic therapy?

Neuropsychopharmacology

Volumn 17, Issue 1, 1997, Pages 34-43

  Ehlers, C L ^a,b   Somes, C ^a   Lopez, A ^a   Kirby, D ^a   Rivier, J E ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b ILTAB   (United States)

Author keywords

Amygdala; Dorsal hippocampus; EEG; ERPs; Frontal cortex; Neuropeptides; Spectral analyses

Indexed keywords

ANXIOLYTIC AGENT; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FRONTAL CORTEX; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RAT; THETA RHYTHM;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; BRAIN; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; HIPPOCAMPUS; MALE; NEUROPEPTIDE Y; RATS; RATS, WISTAR;

EID: 0031007979     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00001-8     Document Type: Article

References (81)

1. Abe M, Saito M, Shiumazu T (1989); Neuropeptide Y and norepinephrine injected into the paraventricular nucleus of the hypothalamus activate endocrine pancreas. Biomed Res 10:431-436
2. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossen MN, Roberts GW, Crow TJ, Tatemoto K, Polak, JM (1983): Neuropeptide Y distribution in human brain. Nature 306(5943)584-586
3. Albers HE, Ferris CF (1984): Neuropeptide Y: Role in lightdark cycle entrainment of hamster circadian rhythms. Neurosci Lett 50(1-3):163-168
4. Allen YS, Adrian TE, Allen JM, Tatamoto K, Crow TJ, Bloom SR, Polak JM (1983): Neuropeptide Y distribution in the rat brain. Science 221(4613):877-879
5. Aoki C, Pickel VM (1989): Neuropeptide Y in the cerebral cortex and the caudate-putamen nuclei: Ultrastructural basis for interactions with GAAGAergic and non-GABAergic neurons. J Neurosci 9(12):4333-4354
6. Aoki C, Pickel VM (1990): Neuropeptide Y in cortex and striatum: Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides. Ann NY Acad Sci 611:185-205
7. Bard JA, Walker MW, Branchek TA, Weinshank RL (1995): Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J Biol Chem 270(45):26762-26765
8. Borbely AA (1992): Effects of hypnotics on sleep regulation and the sleep EEG. Clin Neuropharmacol 15(Suppl 1 Pt A):359A
9. Catzeflis C, Pierroz DD, Rohner-Jeanrenuad F, Rivier JE, Sizonenko PC, Aubert ML (1993): Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 132(1):224-234
10. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL (1985): The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15(4):1159-1181
11. Clark JT, Kalra PS, Crowley WR, Kalra SP (1984): Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115(1):427-429
12. Danger JM, Tonon MC, Jenks BG, Saint-Pierre S, Martel JC, Fasolo A, Breton B, Quirion R, Pelletier G, Vaudry H (1990): Neuropeptide Y: Localization in the central nervous system and neuroendocrine functions. Fundam Clin Pharmacol 4:307-340
13. de Quidt ME, Emson PC (1986a): Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. I. Radioimmunoassay and chromatographic characterization. Neuroscience 18(3):527-543
14. de Quidt ME, Emson PC (1986b): Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18(3)545-618
15. Donchin E, Coles MGH (1988): Is the P300 component a manifestation of context updating? Behav Brain Sci 11:357-374
16. Dumont Y, Fournier A, St-Pierre S, Schwartz TW, Quirion R (1990): Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain. Eur J Pharmacol 191(3): 501-503
17. Ehlers CL (1984): Role of selected neuropeptides in the development of epileptiform discharges. In Fariello RG, Morselli PL, Lloyd KG, Quesney LF, Engel J Jr (eds), Neurotransmitters, Seizures, and Epilepsy II. New York, Raven Press, pp 295-304
18. Ehlers CL (1988): ERP responses to ethanol and diazepam administration in squirrel monkeys. Alcohol 5:315-320
19. Ehlers CL (1989): EEG and ERP responses to naloxone and ethanol in monkeys. Prog Neuropsychopharmacol Biol Psychiatry 13:217-228
20. Ehlers CL, Havstad JW (1982): Characterization of drug effects on the EEG power spectral band time series analysis. Psychopharmacol Bull 18:43-47
21. Ehlers CL, Henriksen SJ, Wang M, Rivier J, Vale W, Bloom FE (1983): Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 278:332-336
22. Ehlers CL, Kaneko WM, Robledo P, Lopez A (1994): Long latency event-related potentials in rats: Effects of task and stimulus parameters. Neuroscience 62(3):759-769
23. Ehlers CL, Reed TK (1987): Ethanol effects on EEG spectra in monkeys: Comparison to morphine and diazepam. Electroencephalogr Clin Neurophysiol 66:317-321
24. Ehlers CL, Reed TK, Wang M, Lebrun CJ, Koob GF (1985): EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat. Psychopharmacology 87:430-433
25. Ehlers CL, Reed TK, Henriksen SJ (1986): Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467-474
26. Ehlers CL, Wall TL, Chaplin RI (1991): Long latency event related potentials in rats: Effects of dopaminergic and serotonergic depletions. Pharamcol Biochem Behav 38: 789-793
27. Ehlers CL, Chaplin RI (1992): Long Latency event-related potentials in rats: The effects of changes in stimulus parameters and neurochemical lesions. J Neural Transm 88:61-75
28. Ehlers C, Kaneko WM, Wall TL, Chaplin RI (1992): Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPs) in rats. Neuropharm 31(4):369-378
29. Ehlers CL, Wall TL, Schuckit MA (1989): EEG spectral characteristics following ethanol administration in young men. EEG Clin Neurophysiol 73:179-187
30. Fuxe K, Agnati LF, Härfstrand A, Zini I, Tatemoto K, Pich EM, Hökfelt T, Mutt V, Terenius L (1983): Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scan 118:189-192
31. Fuxe K, Agnati LF, Härfstrand A, Eneroth P, Cintra A, Tinner B, Pich EM, Aronsson M, Bunnemann B, Lang R, Ganten D (1989): Studies on the neurochemical mechanisms underlying the neuroendocrine actions of neuropeptide Y. In Mutt V, Hokfelt T, Fuxe K, Lundberg JM (eds), Neuropeptide Y. New York, Raven Press, pp 115-136
32. Gehlert DR (1994): Subtypes of receptors for neuropeptide Y: Implications for the targeting of therapeutics. Life Sci 55:551-562
33. Gehrmann JE, Killam JF Jr (1978): Studies of central functional equivalence - Time varying distributions of power in discrete frequency bands of the EEG as a function of drug exposure. Neuropharmacology 17:747-759
34. Gerald C, Walker MW, Vaysse PJ, He C, Branchek TA, Weinshank RL (1995): Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 270(45): 26758-26761
35. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (1996): A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382 (6587):168-171
36. Gray TS, Morley JE (1986): Neuropeptide Y: Anatomical distribution and possible function in mammalian nervous system. Life Sci 38:389-401
37. Grillon C, Ameli R (1994): P300 assessment of anxiety effects of processing novel stimuli. Int J Psychophysiol 17 (3):205-217
38. Grundemar L, Sheikh SP, Wahlestedt C (1993): Characterization of receptor types for neuropeptide Y and related peptides. In Colmers WF, Wahlestedt C (eds), The Biology of Neuropeptide Y and Related Peptides. Totawa, NJ, Humana Press, p 197
39. Gusstafson EL, Card JP, Moore RY (1986): Neuropeptide Y localization in the rat amygdaloid complex. J Comp Neurol 251(3):349-362
40. Heilig M (1995): Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 59(2):201-205
41. Heilig M, Koob GF, Ekman R, Britton KT (1994): Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration TINS 17(2):80-85
42. Heilig M, McLeod S, Brot M, Heinricks SC, Menzaghi F, Koob GF, Britton KT (1993): Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8(4):357-363
43. Heilig M, McLeod S, Koob GF, Britton KT (1992): Anziolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul Pept 41(1):61-69
44. Heilig M, Söderpalm B, Engel JA, Widerlöv E (1989): Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 98(4)524-529
45. Heilig M, Widerlöv E (1990): Neuropeptide Y: An overview of central distribution, functional aspect, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr Scan 82:95-114
46. Heilig M, Widerlöv E (1995): Neurobiology and clinical aspects of Neuropeptide Y. In Nemeroff CB, De Souse EB (eds), Critical Reviews in Neurobiology. 9(2-3):115-136
47. Hendry JHC (1993): Organization of neuropeptide Y neurons in the mammalian central nervous system. In Colmers WF, Wahlestedt C (eds), The Biology of Neuropeptide Y and Related Peptides. Totowa, NJ, Humana Press, p 65
48. Hillyard SA, Kutas M (1983): Electrophysiology of cognitive processing. Annu Rev Psychol 34:33-61
49. Kalra SP, Crowley WR (1992): Neuropeptide Y: A novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to lutenizing hormone. Front Neuroendocrinol 13:1-46
50. Kirby DA, Koerber SC, Craig AG, Feinstein RD, Delmas L, Brown MR, Rivier JE (1993): Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues. J Med Chem 36:385-393
51. Kowall NW, Ferrante RJ, Beal MF et al. (1987): Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striaturn: A combined immunocytochemical and enzyme histochemical study. Neuroscience 20(3):817-828
52. Levine AS, Morley JE (1984): Neuropeptide Y: A potent inducer of consummatory behavior in rats. Peptides 5(6):1025-1029
53. Leibowitz SF (1988): Hypothalamic paraventricular nucleus: Interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci Biobehav Rev 12:101-109
54. Leibowitz SF (1991): A brain neuropeptide Y: An integrator of endocrine, metabolic and behavioral processes. Brain Res Bull 27:333-337
55. Michel MC (1991): Receptors for neuropeptide Y: Multiple subtypes and multiple second messengers. Trends Pharmacol Sci 12(10):389-394
56. Moore RY, Card JP (1985): Visual pathways and the entrainment of circadian rhythms. Ann NY Acad Sci 453:123-133
57. Morley JE, Hernandez EN, Flood JF (1987): Neuropeptide Y increases food intake in mice. Am J Physiol 253(3 Pt. 2):R516-522
58. Mutt V, Hökfelt T, Fuxe K, Lundgerg JM (eds) (1989): Neuropeptide Y. Karlinska Institute Nobel Conference Series. New York, Raven Press
59. Nakagawa Y, Shiosaka S, Emson PC, Tohyama M (1985): Distribution of neuropeptide Y in the forebrain and diencephalon: An immunohistochemical analysis. Brain Res 361(1-2):52-60
60. Parrott RF, Heavens RP, Baldwin BA (1986): Stimulation of feeding in the satiated pig by intracerebroventricular injection of neuropeptide Y. Physiol Behav 36(3):523-525
61. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979): A Stereotaxic Atlas of the Rat Brain. New York, Plenum Press
62. Polich J, Fisher A, Starr A (1983): A programmable multi-tone generator. Behav Res Methods Instrum 15:39-41
63. Polich J (1987): Comparison of P300 from a passive tone sequence paradigm and an active discrimination task. Psychophysiology 24:41-46
64. Robledo P, Kaneko WM, Ehlers CL (1995): Effects of neurotensin on EEG and event-related potentials in the rat. Psychopharmacology 118:410-418
65. Robledo P, Lumeng L, Li T-K, Ehlers CL (1984): Effects of MK 801 and diazepam on the EEG of P and NP rats. Alcohol Clin Exp Res 18(2):363-368
66. Roth WT (1973): Auditory evoked responses to unpredictable stimuli. Psychophysiology 10:125-137
67. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM (1985): Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241(2):138-153
68. Shen CL (1987): Distribution of neuropeptide Y immunoreactivity in the forebrain of the rat. Proc Natl Sci Counc Repub China Part B 11(2):115-127
69. Squires NK, Squires KC, Hillyard SA (1975): Two varieties long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 38:387-401
70. Stanley BG, Daniel DR, Chin AS, Leibowitz SF (1985): Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 6(6):521-524
71. Stanley BG, Leibowitz SF (1984): Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 34(26):2635-2642
72. Tatemoto K, Carlquist M, Mutt V (1982): Neuropeptide Y a novel brain peptide with structured similarities to peptide YY and pancreatic polypeptide. Nature 296(5858): 659-660
73. Verleger R (1988): Event-related potentials and cognition: A critique of the context updating hypothesis and an alternative interpretation of P3. Behav Brain Sci 11:343-356
74. Wahlestedt C, Ekman R, Widerlöv E (1989): Neuropeptide Y (NPY) in the central nervous system: Distribution, effects and possible relationship to neurological and psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 13(1-2):31-54
75. Wahlestedt C, Grundemar L, Kakanson R, Heilig M, Shen GH, Zikowsak-Grojec Z, Reis DJ (1990): Neuropeptide Y receptor subtypes, Y1 and Y2. Ann NY Acad Sci 611:7-26
76. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993): Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259(5094): 528-531
77. Wahlestedt C, Reis DJ (1993): Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets. Annu Rev Pharmacol Toxicol 33:309-352
78. Wahlestedt C, Skagerberg G, Edman R, Heilig M, Sundler F, Hakanson R (1987): Neuropeptide Y (NPY) in the area of the paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res 417:33-38
79. Wahlestedt C, Yanaihara N, Hakanson R (1986): Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Regul Pept 13(3-4): 307-318
80. Weinberg DH, Sirinathsinghji DJ, Tan CP, Shiao LL, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA, Strader CD, Linemeyer DL, MacNeil DJ (1996): Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271(28): 16435-16438
81. Wettstein JG, Barley B, Junien JL (1995): Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65(3):397-414